back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-06-05 11:09 Tx date 2024-06-04 |
$FUSN
Fusion Pharmaceuticals Inc. |
Rawat, Mohit
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Units
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-81,300 vol |
0 | |
| Filed 2024-06-05 11:08 Tx date 2024-06-04 |
$FUSN
Fusion Pharmaceuticals Inc. |
Rawat, Mohit
5 - Senior Officer of Issuer
Direct Ownership
|
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-770,400 vol |
0 | |
| Filed 2024-06-05 11:08 Tx date 2024-06-04 |
$FUSN
Fusion Pharmaceuticals Inc. |
Rawat, Mohit
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$-269,703
-12,843 vol $21.00 each |
0 | |
| Filed 2024-03-12 15:42 Tx date 2022-02-01 |
$FUSN
Fusion Pharmaceuticals Inc. |
Rawat, Mohit
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+55,194 vol |
334,900 | |
| Filed 2024-03-12 15:40 Tx date 2022-02-01 |
$FUSN
Fusion Pharmaceuticals Inc. |
Rawat, Mohit
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+22,706 vol |
279,706 | |
| Filed 2024-01-05 12:17 Tx date 2023-08-31 |
$FUSN
Fusion Pharmaceuticals Inc. |
Rawat, Mohit
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+12,843 vol |
12,843 | |
| Filed 2024-01-05 12:16 Tx date 2021-09-27 |
$FUSN
Fusion Pharmaceuticals Inc. |
Rawat, Mohit
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-01-05 12:03 Tx date 2024-01-04 |
$FUSN
Fusion Pharmaceuticals Inc. |
Rawat, Mohit
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Units
56 - Grant of rights
|
+81,300 vol |
81,300 | |
| Filed 2024-01-05 12:02 Tx date 2021-09-27 |
$FUSN
Fusion Pharmaceuticals Inc. |
Rawat, Mohit
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-01-05 12:02 Tx date 2024-01-04 |
$FUSN
Fusion Pharmaceuticals Inc. |
Rawat, Mohit
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+135,500 vol |
692,500 | |
| Filed 2023-01-09 09:10 Tx date 2023-01-05 |
$FUSN
Fusion Pharmaceuticals Inc. |
Rawat, Mohit
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+300,000 vol |
557,000 | |
| Filed 2021-10-12 09:39 Tx date 2021-09-27 |
$FUSN
Fusion Pharmaceuticals Inc. |
Rawat, Mohit
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+257,000 vol |
257,000 | |
| Filed 2021-10-12 09:37 Tx date 2021-09-27 |
$FUSN
Fusion Pharmaceuticals Inc. |
Rawat, Mohit
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|